Description of the blood test:

Cardiolipin is a key phospholipid found in cell membranes and platelets. Anti-Cardiolipin IgM antibodies are “first-responder” autoantibodies produced by the immune system that mistakenly target these fats. Their presence interferes with normal blood vessel function and the coagulation cascade. Along with the IgG subclass and other markers, these antibodies are a core component in diagnosing Antiphospholipid Syndrome (APS), an autoimmune disorder that causes the blood to clot too easily, leading to potentially dangerous vascular events.

What Does the Test Represent?

• Goal: To detect and measure the concentration of IgM-class antibodies against cardiolipin.
• Main Application: Identifying early or acute autoimmune activity related to blood clots and investigating pregnancy complications.
• Method: Enzyme-Linked Immunosorbent Assay (ELISA) or Chemiluminescence Immunoassay (CLIA).

Collection Recommendations (General)

• Timing: Blood collection is best performed in the morning.
• Fasting: Overnight fasting (8–12 hours) is recommended; plain water is allowed.
• Material: Venous blood (serum).
• Specific Rules: Avoid alcohol and heavy physical exertion for 24 hours before the test. Inform your doctor if you have had a recent viral or bacterial infection, as these can trigger a temporary spike in IgM levels.

Factors Influencing the Result

• Transient Positivity: IgM antibodies often appear temporarily due to infections (like syphilis, Lyme disease, or even the flu). To confirm a chronic condition like APS, the test must remain positive when repeated 12 weeks later.
• Specificity: While IgM is an important marker, it is generally considered slightly less specific for predicting long-term clotting risk than the IgG subclass.
• Medications: Certain drugs (like chlorpromazine or hydralazine) can occasionally induce the production of these antibodies.

When to Take This Test?

• Recommendations: If you have experienced a “provoked” or “unprovoked” blood clot (DVT, pulmonary embolism), a stroke at a young age, or pregnancy issues such as recurrent early miscarriages or unexplained late-term loss.
• Importance: Detecting the IgM subclass ensures that an active or early-stage autoimmune process is not overlooked, especially if the IgG subclass is negative.

Medical Interpretation

• Crucial Note: A single positive IgM result is not a diagnosis. A diagnosis of APS requires a combination of clinical history and persistent lab abnormalities. Only a specialist can “fine-tune” these results by correlating them with your specific symptoms and other diagnostic markers.
• Positive Result (>99th percentile): Suggests Antiphospholipid Syndrome if the result persists for at least 12 weeks and is accompanied by clinical events.
• Low-Positive/Isolated IgM: Often represents a temporary immune response to a recent illness rather than a chronic autoimmune disease.

Possible Further Investigations

• Anti-Cardiolipin IgG: Typically tested alongside IgM to determine the long-term risk profile.
• Anti-Beta-2 Glycoprotein I (IgG and IgM): Additional mandatory markers for the diagnosis of APS.
• Lupus Anticoagulant: A functional clotting test to see how the antibodies behave in the blood.
• ANA (Antinuclear Antibody): To check for underlying conditions like Systemic Lupus Erythematosus (SLE).
• Consultation with a Rheumatologist or Hematologist.

When Does the Next Step Make Sense?

• If the result is positive, the mandatory next step is a repeat test 12 weeks later. If the antibodies are gone, the initial result was likely a temporary reaction to an infection. If they are still present, your doctor will discuss long-term strategies to manage your blood’s clotting tendency and protect your vascular health.
• All clinical decisions must be made by a healthcare professional based on the persistence of the antibody and the patient’s individual risk factors.

👉 If necessary, you can discuss the analysis results with a specialist such as a rheumatologist (Doctors – TAMC) or hematologist (Doctors – TAMC).